Par Drugs & Chemicals Ltd Annual Results: Standalone & Consolidated Reports

Annual Results

Results Snapshot

Figures in Cr

Standalone Annual Results

Mar'25

Mar'24

Mar'23

Mar'22

Mar'21

Mar'20

Mar'19

Annual Analysis Highlights

Net Sales

YoY Growth in year ended Mar 2025 is 5.57% vs -0.11% in Mar 2024

Standalone Net Profit

YoY Growth in year ended Mar 2025 is -7.86% vs 27.98% in Mar 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -14.55% vs 25.32% in Mar 2024

Interest

YoY Growth in year ended Mar 2025 is -27.27% vs -15.38% in Mar 2024

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has fallen from Mar 2024

Compare Annual Results Of Par Drugs & Che. With

Select Peers

Figures in Cr

Standalone Annual Results

Change(INR)

Change(%)

Net Sales

100.97

865.54

-764.57

-88.33%

Other Operating Income

0.00

Total Operating income

100.97

865.54

-764.57

-88.33%

Raw Material Cost

39.41

696.35

-656.94

-94.34%

Purchase of Finished goods

0.00

26.37

-26.37

-100.00%

(Increase) / Decrease In Stocks

-1.28

-9.55

8.27

86.60%

Employee Cost

5.85

35.59

-29.74

-83.56%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

37.49

111.49

-74.00

-66.37%

Total Expenditure (Excl Depreciation)

81.47

860.25

-778.78

-90.53%

Operating Profit (PBDIT) excl Other Income

19.50

5.29

14.21

268.62%

Other Income

2.15

1.95

0.20

10.26%

Operating Profit (PBDIT)

21.65

7.24

14.41

199.03%

Interest

0.08

0.23

-0.15

-65.22%

Exceptional Items

0.00

Gross Profit (PBDT)

21.57

7.01

14.56

207.70%

Depreciation

3.65

5.67

-2.02

-35.63%

Profit Before Tax

17.92

1.34

16.58

1,237.31%

Tax

4.57

0.32

4.25

1,328.12%

Provisions and contingencies

0.00

Profit After Tax

13.36

1.02

12.34

1,209.80%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

13.36

1.02

12.34

1,209.80%

Equity Capital

12.30

8.88

3.42

38.51%

Face Value

10.00

0.00

Reserves

86.67

197.20

-110.53

-56.05%

Earnings per share (EPS)

10.86

1.15

9.71

844.35%

Diluted Earnings per share

10.86

1.15

9.71

844.35%

Operating Profit Margin (Excl OI)

19.31%

0.61%

0.00

18.70%

Gross Profit Margin

21.36%

0.81%

0.00

20.55%

PAT Margin

13.23%

0.12%

0.00

13.11%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Annual - Net Sales

Net Sales 100.97 Cr

in Mar 2025

Figures in Cr

YoY Growth in year ended Mar 2025 is 5.57% vs -0.11% in Mar 2024

Annual - Standalone Net Profit

Standalone Net Profit 13.36 Cr

in Mar 2025

Figures in Cr

YoY Growth in year ended Mar 2025 is -7.86% vs 27.98% in Mar 2024

Annual - Operating Profit (PBDIT)

Operating Profit (PBDIT) 19.50 Cr

in Mar 2025

Figures in Cr

YoY Growth in year ended Mar 2025 is -14.55% vs 25.32% in Mar 2024

Annual - Interest

Interest 0.08 Cr

in Mar 2025

Figures in Cr

YoY Growth in year ended Mar 2025 is -27.27% vs -15.38% in Mar 2024

Annual - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 19.31%

in Mar 2025

Figures in %

YoY Growth in year ended Mar 2025 has fallen from Mar 2024